Gene: SRCIN1
Official Full Name: SRC kinase signaling inhibitor 1provided by HGNC
Gene Summary: Enables protein kinase binding activity. Involved in several processes, including postsynaptic actin cytoskeleton organization; regulation of protein tyrosine kinase activity; and substrate adhesion-dependent cell spreading. Located in actin cytoskeleton and cytoplasm. Is active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25945 | SRCIN1 Knockout cell line (HeLa) | Human | SRCIN1 | 1:3~1:6 | Negative | Online Inquiry |
KO25946 | SRCIN1 Knockout cell line (HCT 116) | Human | SRCIN1 | 1:2~1:4 | Negative | Online Inquiry |
KO25947 | SRCIN1 Knockout cell line (HEK293) | Human | SRCIN1 | 1:3~1:6 | Negative | Online Inquiry |
KO25948 | SRCIN1 Knockout cell line (A549) | Human | SRCIN1 | 1:3~1:4 | Negative | Online Inquiry |
SRCIN1 Gene Knockout Cell Lines are advanced biological research tools designed for the purposeful disruption of the SRCIN1 gene function in mammalian cell lines. This innovative product enables researchers to investigate the specific roles and biological pathways influenced by SRCIN1, a gene implicated in several cellular processes, including signal transduction, cell proliferation, and differentiation. By utilizing CRISPR-Cas9 technology, these knockout cell lines facilitate precise genetic modifications, allowing for the in-depth study of SRCIN1's contributions to oncogenesis, metabolic regulation, and other critical cellular functions.
The mechanism behind these cell lines involves the targeted introduction of double-stranded breaks in the SRCIN1 gene, leading to insertion or deletion mutations that effectively silence its expression. This process allows researchers to generate isogenic cells, providing a controlled environment for experimentation and comparison to wild-type cells. The ability to manipulate the SRCIN1 gene in various cell types makes these knockout lines invaluable tools in both basic research and drug discovery, particularly in the fields of cancer biology and metabolic disorders.
One of the significant advantages of SRCIN1 Gene Knockout Cell Lines over alternative solutions, such as RNA interference-based methods, is their enduring and stable gene knockout, which ensures consistent gene regulation throughout extended experimental timelines. Additionally, these cell lines come with comprehensive validation data, ensuring researchers can rely on their accuracy and reproducibility.
For scientists, clinicians, and pharmaceutical developers focused on understanding the complexities of gene function, these knockout cell lines are unparalleled in their ability to elucidate gene interactions and provide innovative solutions for therapeutic development. By integrating such advanced cellular models into their research, users can significantly enhance the robustness of their findings and accelerate their progress toward meaningful scientific discoveries.
At [Company Name], we pride ourselves on our expertise in developing cutting-edge biological research products backed by rigorous validation and a commitment to advancing scientific knowledge. Our SRCIN1 Gene Knockout Cell Lines exemplify our dedication to providing researchers with tools that enable groundbreaking discoveries in molecular biology and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.